About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Infective Endocarditis: A Decade after Ross Procedure
OS Suman1, MV Teena1, AR Muneer1, N Ramesh1, G Vijayaraghavan1, AN Kalyagin2
1Department of Cardiology, Kerala Institute of Medical Sciences, Trivandrum, India; 2Department of Medicine, Irkutsk State Medical University, Irkutsk, Russia.
Corresponding Author:
Dr. OS Suman
Email: suman_os@yahoo.com
Received: 20-NOV-2016 Accepted: 23-JAN-2017 Published Online: 20-FEB-2017
DOI: http://dx.doi.org/10.17659/01.2017.0019
Abstract
Background: The Ross procedure is an acceptable alternative to conventional aortic valve replacement in selected patients. The Ross procedure was found to have a lower incidence of infective endocarditis during follow-up compared to other traditional aortic replacement procedure. Case Report: We hereby report a 54 year gentleman with infective endocarditis, 10 years after the Ross procedure. Conclusion: Conservative six weeks antibiotic treatment is effective for management of pulmonary homograft endocarditis.
Keywords : Allograft, Autograft, Aortic valve, Endocarditis, Heart Valve Prosthesis.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports
Last updated on Jan 19, 2025